glp 1 telehealth Expert Guide to GLP-1 Companies GLP-1 telehealth programs add up
Description
Glucagon-like Receptor-1 Agonist for Obesity: Weight Loss Outcomes, Tolerability, Side Effects, and Risks
Subsequently, oral formulations and once weekly injections were developed in the 2010s and liraglutide was the first GLP-1 receptor agonist approved for the treatment of obesity in 2014
Monami, M., Lamanna, C., Desideri, C
10.2337/dc14-1625 33 GoswamiC.IwasakiY.YadaT
